A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
RBC G6PD test; G6PD screen
Glucose-6-phosphate dehydrogenase (G6PD) is a type of protein, called an enzyme, that helps red blood cells work properly. The G6PD test looks at the amount (activity) of this substance in a patient's red blood cells.
Blood is typically drawn from a vein, usually from the inside of the elbow or the back of the hand. The site is cleaned with germ-killing medicine (antiseptic). The health care provider wraps an elastic band around the upper arm to apply pressure to the area and make the vein swell with blood.
Next, the health care provider gently inserts a needle into the vein. The blood collects into an airtight vial or tube attached to the needle. The elastic band is removed from your arm. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding.
In infants or young children, a sharp tool called a lancet may be used to puncture the skin and make it bleed. The blood collects into a small glass tube called a pipette, or onto a slide or test strip. A bandage may be placed over the area if there is any bleeding.
No special preparation is usually necessary.
When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging sensation. Afterward, there may be some throbbing.
Your doctor may order this test if you have signs of G6PD deficiency. This means you do not have enough G6PD activity.
Too little G6PD activity leads to the destruction of red blood cells. This process is called hemolysis. When this process is actively occurring, it is called a hemolytic episode.
Hemolytic episodes can be triggered by infections, severe stress, certain foods (such as fava beans), and certain drugs, including:
If this test is done during a hemolytic episode it may be falsely positive and misleading. This is because the cells most likely to have low G6PD levels (older cells) have been destroyed, and those remaining may show normal G6PD levels.
After recovery from the episode, older cells will show lower levels of G6PD, resulting in a positive test.
Schwartz RS. Autoimmune and intravascular hemolytic anemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 164.
Yee DL, Bollard CM, Geaghan SM. Appendix: normal blood values: selected reference values for neonatal, pediatric, and adult populations. In: Hoffman R, Benz EJ, Shattil SS, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 164.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885